Search Results

Your search matched 478 results

#151

A Different Kind of Match Made in Heaven | Blog

What does the largest app for meeting new people and the NHS Blood and Transplant organization have in common?

#152

New Tools and Partnerships: The Necessity of Optimizing Patient Care | Blog

The general perception is that the healthcare industry has lagged behind with innovations using technology and service design.

#153

Zeo: The big ugly retainer of self trackers | Blog

The readers and writers over at MobiHealthNews and elsewhere have been talking about Zeo shutting its doors.

#154

PUSHBACK ON RARE DRUG PRICES: NOT SO RARE AFTER ALL | In The Media

There’s no doubt the “pricing crisis,” has taken a heavy toll on the reputation of the biopharmaceutical industry.

#155

mHealth for seniors - sooner than you think | Blog

In almost every region around the world, you can find some version of “The mHealth Report.”

#156

Intriguing New Hope in the Opioid Crisis | Blog

Indian medical device manufacturer DyAnsys recently announced the U.S.

#157

YESTERDAY'S PICKET IS TODAY'S E-PROTEST WHEN ACTIVISM HIJACKS YOUR BRAND | Perspectives

The Web is littered with examples of the public decrying corporate missteps.

#158

In Return for Your Foodstagrams, Your Blood, and Your DNA, Nestlé Offering Smoothies | Blog

Nestlé, the brand you might associate first with such decadent confections as Crunch bars, Laffy Taffy, and Toll House cookies, has made a decided turn toward the healthful.

#159

Trend Tracking: Caregivers Are Micro Influencers Too | Blog

Researchers at Indiana University-Purdue University Indianapolis recently announced a new tool available for Alzheimer’s patients’ caregivers – a ‘friend-sourcing’ app to help make more meaningful connections and open a new door for communicating and supporting one another.

#160

Choice vs. | Blog

Making decisions is tough.

#161

The Week That Was: Crises in Communications | Blog

No matter whether you were the lone staffer in your office or relaxing on a beach somewhere this past week, we’ve got the run down on the latest healthcare headlines—the good, the bad and the ugly—to help you get you back up to speed.

#162

Emoji Overload | Blog

Think that emoji’s have jumped the shark?

#163

Non-adherence and Nudges | Blog

In recent years, countless life science leaders have been exploring ways to harness the power of behavioral science to combat the looming threat of healthcare’s biggest challenges.

#164

Meet Ada, Your Personal AI Health Consultant | Blog

Born in mid-2016, Ada is now the #1 medical app in over 130 countries and recently won a Cannes Lions award for innovation and a silver winner at the Clios.

#165

Doximity wins doctor social wars | Blog

Every year around this time Manhattan Research publishes a list of the top apps preferred by doctors.

#166

What Else Is Your Phone Tracking? | Blog

We’re quite used to thinking about our smartphone as a tool to track wellness—a parking lot for apps that can keep tabs on exercise, caloric intake, heart rate, sleep, and plenty of other things.

#167

Introducing Amazon’s New and Exclusive Medical Device Brand | Blog

In recent weeks, Amazon and Arcadia Group announced the launch of a series of consumer-grade medical devices under their new brand Choice.

#168

The Week That Was: We only ride in style | Blog

Employers wield enormous influence in deciding the care their employees receive – yet they aren’t always considered a core “stakeholder” in the healthcare debate.

#169

40% of Surgeons Say: Procurement Picks the Product | Blog

The first line of a new report from Bain & Company really says it all: “For those working on the front line of US healthcare, the pace of change must seem unrelenting.”

#170

Wellness in the Workplace Turns to Genomic Testing | Blog

With healthcare expenses always seemingly on the rise, if you had the opportunity to reduce healthcare costs in your company by $1,464 annually per employee would you?

#171

Alex Azar is getting busy & other healthcare headlines | Blog

It's not even Thanksgiving, and we've already broken out the snow boots and shovels.

#172

Looking at National Data Privacy Laws in the US | Blog

By now you’ve probably heard of GDPR, the strict data privacy standards that went into effect in Europe this year.

#173

F.D.A. | Blog

An expert panel that advises U.S. federal regulatory authorities has recommended approval of Esketamine, Johnson & Johnson’s brand-new treatment for depression.

#174

Accumulators, cannabinoids & opioids (Intrigued? | Blog

Happy Monday, readers!

#175

Precision Medicine Initiative Creating Custom Cures | Blog

A $60 million federal program is aiming to bring the benefits of precision medicine to a diverse spread of Wisconsin communities.

#176

Gotham’s Newest Hero | Blog

For the victims of generational healthcare inequalities, Gotham’s next great hero may not wear a cape, but still has some nifty tricks in her utility belt.

#177

4 things that never belong together: oat milk, mayochup, opioids & drug pricing | Blog

Whether you spent the weekend jamming at a music festival in the sunny, warm desert, or doing something more mundane like taxes switching between heat and air conditioning in your apartment, you may have missed this week’s healthcare and crisis comms headlines.

#178

The Week That Was: Yaaaas Meal | Blog

What do vacationers on a cruise ship in St.

#179

Big Pharma + Genetics Partnership | Blog

Recently, GSK and 23andMe announced a four-year collaboration aimed at identifying new drug targets, better supporting specific subpopulations and accelerating clinical progress.

#180

Amazonian Innovation: It’s as Easy as 3-2-1 | Blog

Before this year’s 16th annual eyeforpharma convention even officially began, Amazon was there, empowering pharma leaders by teaching them new ways from their approach to innovation.